Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

The 1st time the FDA rescinded their tentative approval on the 4 additional focalinxr strengths took IPCI's share price from 3.75 down to 2.60's on low volume with none of the insider/institutional positions being reduced...which was proof positive that the 1st sell off was all spooked retail and shorts.

And now that we've had the 2nd such sell off when the FDA has again rescinded tentative approval until bioequivalence gets submitted in approx. 60 days...it's worth noting that the decline has been from 3.87 into the 2.40's on the same small volume as the 1st time!

So although we know that much of the selling both times has been from spooked retail...we also know the +1.1M short entity involved is here for a reason...and unless the short entity knows something the new IPCI CFO doesn't(CFO just bought 100K open market shares above $3)...the evidence speaks loudly to corruption games afoot of some kind...as both sell offs commenced a few days prior to both FDA rescissions...and when that happens on a Nasdaq stock that has done every single thing required to meet and exceed all FDA criteria to the point where they're 100% at the FDA's mercy in granting the 4 long overdue ANDA approvals...the only possible explanation that makes sense is that we're seeing corruption games at their finest as some entity does everything in their power to attempt to shake retail out.

I haven't seen any of us long term ihubbers selling though...so it's only a matter of time 'til the FDA grants at least 1 of the 4 ANDA's already at the 4 plus year point awaiting FDA approval...and when that 1st of 4 ANDA approvals finally hits...we're going to enjoy watching that +1.1M short cover.

The single best sign of what the future holds here couldn't be made any clearer than the new ex-TEVA CFO buying 100,000 shares on the open market starting in May...as he clearly sees a plethora of positivity approaching regardless of all the last minute unexpected hurdles/obstacles presented.